A Phase IV, Open Label, Single-center Extension Study, to Evaluate the Long-term Persistence of Immune Responses After Post-exposure Prophylaxis With Purified Chicken-embryo Cell Rabies Vaccine in Chinese Children
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Apr 2017 Status changed from recruiting to completed.
- 19 Jan 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017.
- 19 Jan 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Apr 2017.